Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/256069
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMeagher, Eileen Mary-
dc.contributor.authorTrivedi, Mahendra Kumar-
dc.contributor.authorBranton, Alice-
dc.contributor.authorTrivedi, Dahryn-
dc.contributor.authorNayak, Gopal-
dc.contributor.authorMondal, Sambhu Charan-
dc.contributor.authorJana, Snehasis-
dc.date.accessioned2018-08-17T06:25:04Z-
dc.date.available2018-08-17T06:25:04Z-
dc.date.issued2018-07-05-
dc.identifier.citationMeagher EM, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line. J Pharmaceu Pharmacol. 2018; 6(1): 6.en_US
dc.identifier.issn2327-204X-
dc.identifier.urihttps://www.trivedieffect.com/the-science/biotech/publication/healers-science/nutraceuticals/an-alternative-therapeutic-approach-on-bone-cells-differentiation-after-administration-of-biofield-energy-treated-vitamin-d3-in-mg-63-cell-line/-
dc.identifier.urihttp://www.avensonline.org/fulltextarticles/JPP-2327-204X-06-0023.html-
dc.identifier.urihttp://dl.umsu.ac.ir/handle/Hannan/256069-
dc.description.abstractThe objective of the current experiment was to evaluate the potential of Consciousness Energy Healing-based test items (Vitamin D3 and DMEM) on bone parameters. Both the TI were distributed into two individual parts. One part of each samples was received Consciousness Energy Healing Treatment by Eileen Mary Meagher and those samples were labelled as the Biofield Treated (BT) samples, while the other parts of each samples were denoted as the untreated test items (UT). Cell viability data showed more than 71% viable cells signifies a safe and nontoxic profile of test items on MG-63 cell line. ALP was significantly increased by 132.18% and 126.52% in BT-DMEM+UT-TI and BT-DMEM+BT-TI, respectively at 50 µg/mL; while 139.06% (at 0.1 µg/mL) in UT-DMEM+BT-TI compared to untreated. Collagen was significantly increased by 172.76% at 1 µg/mL in UT-DMEM+BT-TI, while 89.65% in BT-DMEM+UT-TI at 10 µg/mL than untreated. Additionally, collagen was significantly increased by 111.2% in BT-DMEM+UT-TI at 50 µg/mL, while 113.16% in BT-DMEM+BT-TI at 100 µg/mL than untreated. The percent of bone mineralization was significantly increased by 206.21%, 168.74%, and 224.82% in UT-DMEM+BT-TI, BT-DMEM+UT-TI, and BT-DMEM+BT-TI, respectively at 0.1 µg/mL compared with the untreated. In addition, percent of bone mineralization data showed a significant increased by 190.63%, 181.07%, and 245.41% in UT-DMEM+BT-TI, BT-DMEM+UT-TI, and BT-DMEM+BT-TI, respectively at 1 µg/mL than untreated. Moreover, at 10 µg/mL it was significantly increased by 129.44%, 111.76%, and 109.81% in UT-DMEM+BT-TI, BT-DMEM+UT-TI, and BT-DMEM+BT-TI, respectively at 10 µg/mL with respect to untreated. Based on the study outcomes it emphasized that Biofield Energy Treatment could regulates the osteoblast function, improves bone mineralization, and calcium absorption in wide range of bone disorders along with wide range of autoimmune diseases.en_US
dc.language.isoen_USen_US
dc.publisherAvens Publishing Groupen_US
dc.subjectEnergy healingen_US
dc.subjectThe Trivedi effect®en_US
dc.subjectOsteosarcoma cellsen_US
dc.subjectVitamin Den_US
dc.subjectBone disordersen_US
dc.subjectBone mineralizationen_US
dc.titleAn Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell lineen_US
dc.typeArticleen_US
Appears in Collections:منابع مشترک



Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.